Lodenosine

Lodenosine
Names
	IUPAC name [(2S,4S,5R)-5-(6-Amino-9H-purin-9-yl)-4-fluorooxolan-2-yl]methanol
Identifiers
CAS Number	110143-10-7 ;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL501916 ;
ChemSpider	65151 ;
KEGG	D04759 ;
PubChem CID	72180;
UNII	3WB2LGT4R1 ;
CompTox Dashboard (EPA)	DTXSID90149154 ;
	InChI InChI=1S/C10H12FN5O2/c11-6-1-5(2-17)18-10(6)16-4-15-7-8(12)13-3-14-9(7)16/h3-6,10,17H,1-2H2,(H2,12,13,14)/t5-,6-,10+/m0/s1 Key: KBEMFSMODRNJHE-JFWOZONXSA-N ; InChI=1/C10H12FN5O2/c11-6-1-5(2-17)18-10(6)16-4-15-7-8(12)13-3-14-9(7)16/h3-6,10,17H,1-2H2,(H2,12,13,14)/t5-,6-,10+/m0/s1 Key: KBEMFSMODRNJHE-JFWOZONXBK;
	SMILES F[C@H]3C[C@H](O[C@H]3n2cnc1c(ncnc12)N)CO;
Properties
Chemical formula	C10H12FN5O2
Molar mass	253.23 g/mol
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

Lodenosine is a failed experimental agent for the treatment of HIV. Its development was discontinued on January 11, 2001.^[1]

^ "Drug Profile: Lodenosine". AdisInsight. Adis International Ltd, part of Springer Science+Business Media. Retrieved 4 December 2015.